Emerging Biotech

Chromatin Bioscience Partners with Astellas to Advance Cell-Selective Gene Expression Technologies

Chromatin Bioscience, a leader in the design of synthetic promoters and gene control systems, is pleased to announce a collaboration agreement with As...

 April 15, 2025 | News

Thermo Fisher Scientific and NSG BIO Join Forces to Boost Singapore’s Biotech Innovation

The collaboration aims to provide advanced resources and scientific expertise to accelerate innovation and drive sustainable growth  Thermo Fisher Sc...

 April 09, 2025 | News

Singapore’s Engine Biosciences and EDDC Launch First-Ever Partnership to Advance Precision Cancer Therapies

This marks the first-ever collaboration between Engine Biosciences and Experimental Drug Development Centre (EDDC),&nb...

 April 08, 2025 | News

PeptiGrowth to Launch Synthetic KGF Alternative Peptide PG-012 in April 2025 for Regenerative Medicine Applications

PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Junichiro Ishizuka) has successfully developed a novel synthetic peptide called "KG...

 April 02, 2025 | News

Yingli Pharma Receives FDA Clearance to Launch Global Phase 3 Trial of Linperlisib for Relapsed/Refractory PTCL

Shanghai Yingli Pharmaceutical Co., Ltd. (Yingli Pharma), a clinical stage biotechnology company developing oral small molecule drugs for cancer, metabolic...

 April 02, 2025 | News

IASO Bio Secures First Approval Outside Mainland China for Equecabtagene Autoleucel in Macau

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative ce...

 March 31, 2025 | News

Gene Solutions Achieves Landmark Validation for Asia’s First Clinically Proven Multi-Cancer Blood Test, SPOT-MAS

 Gene Solutions, a leading biotech company in Asia, proudly announces a groundbreaking achievement in cancer early detection.  Common cance...

 March 27, 2025 | News

AnHorn Medicines Doses First Subject in U.S. Phase I Trial for AH-001, a First-in-Class Protein Degrader Targeting Hair Loss

AnHorn Medicines, a pioneering AI-driven new drug discovery company, is pleased to announce that, AH-001, a first-in-class protein degrader for androg...

 March 27, 2025 | News

Sichuan Kelun-Biotech Gets Green Light for First Radionuclide-Drug Conjugate Clinical Trial

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the invest...

 March 26, 2025 | News

SineuGene Therapeutics Receives FDA IND Clearance for First-in-Class ALS Gene Therapy SNUG01

SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders,  announce...

 March 25, 2025 | News

Shanghai Moyom’s Aphranel® MagiCCrystal Becomes First NMPA-Approved CaHA Filler in China

Shanghai Moyom Biotechnology's high-profile brand, Aphranel® MagiCCrystal CaHA Filler, has officially obtained Class III Medical Device ...

 March 24, 2025 | Regulatory

Alamar Biosciences Expands APAC Presence with Five New Distribution Partnerships

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce the signing of five new dis...

 March 20, 2025 | News

Alphamab Oncology and CSPC’s Anti-HER2 ADC JSKN003 Secures Breakthrough Therapy Designation in China

Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic...

 March 19, 2025 | News

Chance Pharmaceuticals Secures New Funding to Advance Phase III Trials for CXG87 and Expand Inhalation Therapy Pipeline

Chance Pharmaceuticals ("Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapi...

 March 18, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close